ML753286

Modify Date: 2026-08-21 18:19:38

ML753286 Structure
ML753286 structure
Common Name ML753286
CAS Number 1699720-89-2 Molecular Weight 355.43
Density N/A Boiling Point N/A
Molecular Formula C20H25N3O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of ML753286


ML753286 is an orally active and selective BCRP (Breast cancer resistance protein) inhibitor with an IC50 of 0.6 μM. ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions, and is stable in plasma cross species[1].

 Names

This table lists Chinese names, IUPAC names and various aliases of this chemical substance.

Name ML753286

 ML753286 Biological Activity

This table contains bioactivity, target information and biological‑assay experimental data of this compound.

Description ML753286 is an orally active and selective BCRP (Breast cancer resistance protein) inhibitor with an IC50 of 0.6 μM. ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions, and is stable in plasma cross species[1].
Related Catalog
Target

IC50: 0.6 μM (BCRP)[1]

In Vitro ML753286 has IC50 values of >30, 0.6, and 39.0 μM for the inhibition of P-gp-, BCRP-, and OATP mediated transport, respectively[1].
In Vivo ML753286 (25- or 50-mg/kg (PO); 10 or 20 mg/kg (IV); 0.083-24 hours) appears to completely inhibit Bcrp functions in rats at 25 mg/kg PO or at 20 mg/kg IV. The tmax values in plasma were 1.4, 4.0, and 4.1 hours in Bcrp KO rats, WT rats pre-administered 25-mg/kg ML753286, and WT rats pre-administered 50-mg/kg ML753286, respectively[1]. Animal Model: Male Bcrp KO (Abcg2−/−) and WT (Wistar) Rats[1] Dosage: 25- or 50-mg/kg (PO); 10 or 20 mg/kg (IV) (Pharmacokinetic Study) Administration: PO or IV; 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 hours Result: The tmax values in plasma were 1.4, 4.0, and 4.1 hours in Bcrp KO rats, WT rats pre-administered 25-mg/kg ML753286, and WT rats pre-administered 50-mg/kg ML753286, respectively.
References

[1]. Liao M, et al. Preclinical absorption, distribution, metabolism, excretion and pharmacokinetics of a novelselective inhibitor of breast cancer resistance protein (BCRP). Xenobiotica. 2018 May;48(5):467-477.

 Chemical & Physical Properties

This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.

Molecular Formula C20H25N3O3
Molecular Weight 355.43
InChIKey XDVXQQDQFWVCAU-MZPVMMEZSA-N
SMILES COc1ccc2c3c([nH]c2c1)C(CC(C)C)N1C(=O)C(C)NC(=O)C1C3

 ML753286 | FAQ

This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.

Q: What is the English name of ML753286?
A: The English name of ML753286 is ML753286.
Q: What are the uses of ML753286?
A: Main uses of ML753286: ML753286 is an orally active and selective BCRP (Breast cancer resistance protein) inhibitor with an IC50 of 0.6 μM. ML753286 has high permeability and low to medium clearance in rodent and human liver S9 fractions, and is stable in plasma cross species[1].
Q: What is the CAS number of ML753286?
A: CAS number of ML753286 is 1699720-89-2.
Q: What is the molecular weight of ML753286?
A: Molecular weight of ML753286 is 355.43.
Q: What is the SMILES notation of ML753286?
A: SMILES notation of ML753286 is COc1ccc2c3c([nH]c2c1)C(CC(C)C)N1C(=O)C(C)NC(=O)C1C3.
Q: What is the Chinese name of 1699720-89-2?
A: Chinese name of 1699720-89-2 is ML753286.
Q: What is the molecular formula of ML753286?
A: Molecular formula of ML753286 is C20H25N3O3.
Q: What is the InChIKey of ML753286?
A: InChIKey of ML753286 is XDVXQQDQFWVCAU-MZPVMMEZSA-N.

 ML753286factory

This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.

Shanghai Nianxing Industrial Co., Ltd
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.